Bio-heart Secures Indonesia Approval for Iberis RDN System
Medical Device

Bio-heart Secures Indonesia Approval for Iberis RDN System

BioArctic Partner Eisai Submits EMA Application for Four-Week Lecanemab Dosing in Alzheimer's
CompanyDrug

BioArctic Partner Eisai Submits EMA Application for Four-Week Lecanemab Dosing in Alzheimer’s

Nuance Pharma Secures NMPA Review for Ensifentrine COPD Maintenance Therapy
CompanyDrug

Nuance Pharma Secures NMPA Review for Ensifentrine COPD Maintenance Therapy

ASCP Launches $250K Grants for mCRC Biomarker Testing with Pfizer, ASCO
Company

ASCP Launches $250K Grants for mCRC Biomarker Testing with Pfizer, ASCO

Boehringer Ingelheim Licenses Simcere’s SIM0709 Bispecific for Inflammatory Bowel Disease
CompanyDeals

Boehringer Ingelheim Licenses Simcere’s SIM0709 Bispecific for Inflammatory Bowel Disease

Visen Pharma Secures NMPA Approval for Skytrofa in Pediatric Growth Hormone Deficiency
CompanyDrug

Visen Pharma Secures NMPA Approval for Skytrofa in Pediatric Growth Hormone Deficiency

Sunshine Lake Pharma and Xtalpi Form AI Drug Discovery Joint Venture
CompanyDeals

Sunshine Lake Pharma and Xtalpi Form AI Drug Discovery Joint Venture

HanchorBio Partners with WuXi Biologics on Next‑Gen Fusion Protein Manufacturing
CompanyDeals

HanchorBio Partners with WuXi Biologics on Next‑Gen Fusion Protein Manufacturing

CompanyDrug

Ascletis Doses First Patient in US Phase II Diabetes Study for Oral GLP‑1 ASC30

Knature Biopharm Files Hong Kong IPO Backed by NAD+ Mitochondrial Platform
CompanyDeals

Knature Biopharm Files Hong Kong IPO Backed by NAD+ Mitochondrial Platform

CompanyDrug

Sanofi’s Amlitelimab Hits Phase III Goals in Atopic Dermatitis, Targets Q4W/Q12W Dosing Edge

MicroPort Endovascular’s Talos Stent Graft Secures EU CE MDR Certification
Medical Device

MicroPort Endovascular’s Talos Stent Graft Secures EU CE MDR Certification